DR. THOMAS WESLEY FILARDO, M.D.
Marriage and Family Therapists at Creek Rd, Cincinnati, OH

License number
Ohio 35058656
Category
Osteopathic Medicine
Type
Family Medicine
Address
Address
4545 Creek Rd, Cincinnati, OH 45242
Phone
(513) 769-6542

Personal information

See more information about THOMAS WESLEY FILARDO at radaris.com
Name
Address
Phone
Thomas Filardo, age 79
3724 Monets Ln, Cincinnati, OH 45241
Thomas W Filardo, age 79
3724 Monets Ln, Cincinnati, OH 45241

Professional information

Thomas W Filardo Photo 1

Dr. Thomas W Filardo, Cincinnati OH - MD (Doctor of Medicine)

Specialties:
Family Medicine
Address:
4545 Creek Rd, Cincinnati 45242
(513) 769-6542 (Phone), (513) 769-6542 (Fax)
FILARDO, THOMAS WESLEY MD
3724 Monets Ln, Cincinnati 45241
(513) 769-6542 (Phone)
Certifications:
Family Practice, 1996
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Illinois At Chicago / College of Medicine
Graduated: 1971
St Vincents Hosp Med Ctr
Kansas City Genl Hosp


Thomas Wesley Filardo Photo 2

Thomas Wesley Filardo, Cincinnati OH

Specialties:
Family Physician
Address:
4545 Creek Rd, Cincinnati, OH 45242
Education:
University of Illinois, College of Medicine - Doctor of Medicine
Truman Medical Center-Hospital Hill - Residency - Pathology


Thomas Filardo Photo 3

Obesity Therapy And Heart Rate Variability

US Patent:
2012017, Jul 5, 2012
Filed:
Dec 29, 2010
Appl. No.:
12/980710
Inventors:
Jason L. Harris - Mason OH, US
Aaron C. Voegele - Loveland OH, US
Thomas W. Filardo - Cincinnati OH, US
Tamara C. Baynham - Piscataway NJ, US
Mark S. Ortiz - Milford OH, US
Assignee:
ETHICON ENDO-SURGERY, INC. - Cincinnati OH
International Classification:
A61M 37/00
US Classification:
604 20
Abstract:
Methods and devices are provided for delivering obesity therapy to a patient. In general, the methods and devices allow for onset of a patient eating solid food, e.g., the patient beginning a meal, to trigger delivery of an obesity therapy to a patient. The obesity therapy can be delivered to the patient for a limited period of time such that the patient stops receiving the obesity therapy prior to a second onset of the patient eating solid food, e.g., the patient beginning a second meal, which can trigger a second delivery of the obesity therapy to the patient for a limited period of time.